The frequency of resistant mutant virus before antiviral therapy.
about
Modeling the within-host dynamics of HIV infectionAnalysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patientsModeling antiretroviral drug responses for HIV-1 infected patients using differential equation modelsUnusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1Adherence and drug resistance: predictions for therapy outcomeStructural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV proteaseTiming the emergence of resistance to anti-HIV drugs with large genetic barriersHIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirsStanding genetic variation and the evolution of drug resistance in HIVEstimating HIV-1 fitness characteristics from cross-sectional genotype dataStability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance GenotypingEvolutionary dynamics of HIV at multiple spatial and temporal scales.High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.Immunological transitions in response to antigenic mutation during viral infection.Minority variants of drug-resistant HIV.Estimating frequencies of minority nevirapine-resistant strains in chronically HIV-1-infected individuals naive to nevirapine by using stochastic simulations and a mathematical model.Rapid emergence of protease inhibitor resistance in hepatitis C virus.The Effect of Interference on the CD8(+) T Cell Escape Rates in HIV.What do mathematical models tell us about the emergence and spread of drug-resistant HIV?Production of resistant HIV mutants during antiretroviral therapy.A simple relationship between viral load and survival time in HIV-1 infection.Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy.Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugsAntiretroviral dynamics determines HIV evolution and predicts therapy outcome.Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibilityHIV recombination: what is the impact on antiretroviral therapy?Dynamics of CD4+ T cells in HIV-1 infection.Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients.Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP.Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine.Evolution of resistance during clonal expansion.A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants.Expected Effect of Deleterious Mutations on Within-Host Adaptation of Pathogens.Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection.Durable strategies to deploy plant resistance in agricultural landscapes.Mathematical Models of HIV Latency.Recombination in HIV and the evolution of drug resistance: for better or for worse?
P2860
Q21245370-B75FE4F0-5536-4149-8233-6C740C809CD7Q24795766-A9FC12F3-BB09-444A-B24F-213B972CECC4Q27015861-61A81FE5-56B3-49BA-BE6E-0554D07E2C53Q27469694-B022C1AD-6F88-445E-99BB-15A7AAD40384Q27477742-4063A558-1FD3-4952-8669-6880CCAC2746Q27621075-263DE277-DDD6-4720-80EF-197BA51521BCQ28474857-59A281B9-F913-427B-9340-3E0BFB7766D6Q28477500-64E27AAF-83F6-4F6D-9828-6D79795C551AQ28484153-99A7FD9F-CA28-4F8E-882E-E2CE3B2CAE23Q28544753-2112618F-07F8-4115-8FD2-7AE07144F1AEQ28546274-04628ED8-FAC7-4306-B843-76A031474E33Q30416280-08C71594-7384-4BF3-BF08-154A8C0EC2EAQ33911980-140062D8-47C5-4F32-A003-DD1F02E36718Q34047035-FF7E6BF7-9503-495E-8957-0EA6CAE1B6A9Q34047780-B1AC820A-3149-4F02-A570-0F2081504586Q34120725-4C46064F-C46B-495E-8791-F904A131E48DQ34551913-27D811DD-67E4-41DD-946B-E7343237D67EQ34936638-8126F71F-7646-4103-A86E-8FAEEC8D6E1AQ34989198-BC400A57-0E84-4CEA-B993-6EC99189D1D1Q35165357-35702DCB-5B2E-4F47-9D55-ED60AE15AE1CQ35655811-258A1C84-2BCC-4CE9-9215-FCCC62C4D98DQ35699612-F414C6B4-937E-4BD0-B5CE-06BED7760184Q35842525-43FF1081-D865-4546-8940-FE0C5F23AA9FQ36091918-F167719A-9BB1-450F-B970-92E6E51ABA8CQ36369127-F2037C7C-4D86-4008-BF23-CC5BD0C7CEE6Q36374300-7F3697D6-D83E-4AFC-BE4C-CCADCF058A0EQ36492224-5646FD7D-E005-4E90-91F7-5A50CBB5582EQ36539852-B20E458A-CDD7-4702-9375-5F990E66A1B3Q36772336-1AD700C8-12F6-4756-9D4F-7C3659B82D12Q37550353-EA2BC5BE-AD49-4FDE-AF6A-AA353A7288DCQ37590197-EB40DF20-6B86-4297-8396-E93C56D871A3Q39551661-6E2F38B8-F1D1-490D-8FE9-2F3E30F1F61BQ40288205-8FFD0CD9-9E26-45E6-86C3-D090F41017DAQ40415552-3F6EDE36-79BE-4165-8FD7-E31688418D1CQ40674710-DE2A8BCB-0A96-46CD-BC2E-B4F11A8FBF2DQ41140967-152C4AA7-C67E-4F5C-8517-CB63182E56B2Q41368316-E852C96F-EAC2-47C3-9690-E09CA9DE73EBQ43482913-BEEACD75-3891-4F83-81AD-EA6FDFF7C467Q47574091-F1D36965-A0D1-473F-A403-DFD447C453ECQ53905007-465CBFA5-FE50-4145-BCDC-F1A495BFFA83
P2860
The frequency of resistant mutant virus before antiviral therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The frequency of resistant mutant virus before antiviral therapy.
@en
The frequency of resistant mutant virus before antiviral therapy.
@nl
type
label
The frequency of resistant mutant virus before antiviral therapy.
@en
The frequency of resistant mutant virus before antiviral therapy.
@nl
prefLabel
The frequency of resistant mutant virus before antiviral therapy.
@en
The frequency of resistant mutant virus before antiviral therapy.
@nl
P1433
P1476
The frequency of resistant mutant virus before antiviral therapy.
@en
P2093
P304
P356
10.1097/00002030-199805000-00006
P407
P577
1998-03-01T00:00:00Z